FormBlends
FormBlends pairs compounded GLP-1s with a large peptide storefront, including sermorelin, NAD+, glutathione and PT-141 by the vial. It names three pharmacies and prints each vial's strength, but not the dose you would take from it.
Review by Leah Garner, clinical-evidence editor · Updated September 2026
The short version
FormBlends is unusually open about its supply chain, with three named pharmacies and a subscribe or one-time price on every vial. Its evidence pages are weaker than they look: a sermorelin study it describes is never identified, and its PT-141 page gets the approved drug's form wrong. Most of its catalog is research peptides this site does not cover.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Glutathione injection, from $107/mo
Visit FormBlends →FormBlends is a cash-pay online seller of compounded GLP-1s and peptides, with smaller lines in hormones, hair, skin and sexual health. The peptides this site covers are sermorelin, NAD+ as an injection or nasal spray, glutathione and PT-141. Around them sits a long shelf of research peptides and blends. Its GLP-1 orders run through a separately branded checkout, and its peptide orders through a separate cart.
What FormBlends prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)From $190/mo
- TirzepatideFDA-approved
- Injection (compounded)From $239/mo
Semaglutide and tirzepatide are sold at one price at every dose. Shipping is included on the GLP-1 plans, and lab work is not.
Sexual health
- PT-141 (bremelanotide)FDA-approved
- Injection (compounded)From $170/mo
PT-141 is a 5 mL vial at 2 mg per mL, injected once about 45 minutes before sex. The strength of each injection is left to the provider. The page says the FDA approved a nasal spray of bremelanotide, but the approved product, Vyleesi, is an injection.
Longevity
- GlutathioneLegal to compound
- Injection (compounded)From $107/mo
- NAD+Legal to compound
- Injection (compounded)From $161/mo
- Nasal spray (compounded)From $134/mo
NAD+ comes as a 1,000 mg vial at 100 mg per mL, with no dose printed, or as a nasal spray at 300 mg per mL used once or twice daily. Glutathione is a 2,000 mg vial at 200 mg per mL, again with no dose.
Recovery
- SermorelinLegal to compound
- Injection (compounded)From $158/mo
Sermorelin is a 15 mg vial at 3 mg per mL in 5 mL. The page prints no dose and no schedule; it only describes a study of nightly injections.
Sleep
- SermorelinLegal to compound
- Injection (compounded)From $158/mo
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
Prescriptions are written by independent, state-licensed MDs, DOs, NPs and PAs who belong to a medical group separate from FormBlends. The site names no individual clinician. Its provider page says it will not invent doctor biographies, and until it adds a named review process the clinician who reads your intake stays anonymous.
You complete an online questionnaire, and a clinician reviews it. Where the clinician thinks it necessary, or your state requires it, you may be asked for a video or phone visit before a prescription. A check-in is requested before any dose change. The longevity page promises unlimited follow-up messages with the care team at no extra cost.
Are labs required?
Not included
No page requires bloodwork before a peptide or a GLP-1. The pricing page says lab work is not included and suggests yearly labs with a primary care clinician.
Ready to start with FormBlends?
Lowest listed price: Glutathione injection, from $107/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The GLP-1 figures cite their trials and add that they are not outcomes for compounded products, which is the right limit to state. The PT-141 figure also names its trials. The sermorelin page is the weak one: it quotes a 30 to 40% rise in IGF-1 and a study of 118 adults without identifying either. Its evidence list holds only two ipamorelin papers.
| On FormBlends’s site | Source it gives |
|---|---|
| On FormBlends’s site“14.9% Semaglutide … STEP 1 TRIAL · NEJM 2021 · N=1,961” | Source it givesSTEP 1, named on the page |
| On FormBlends’s site“roughly 40% of participants reported meaningful improvement in desire, compared with approximately 20% on placebo” | Source it givesRECONNECT trials, named on the page |
| On FormBlends’s site“Increases IGF-1 by 30-40%” | Source it givesNone given |
Sold by FormBlends, not listed here
- BPC-157
- On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- Tesamorelin
- Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
- MOTS-c
- On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- BPC-157, alone and in blends
- On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- MOTS-c, alone and in blends
- On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- Tesamorelin, alone and in blends
- Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
- GHK-Cu injection
- GHK-Cu may be compounded only in a non-injected form, and FormBlends no longer sells its topical serum.
- AOD-9604, DSIP, epithalon, gonadorelin, LL-37, thymosin alpha-1, selank and semax
- Research peptides outside the compounds this site covers.
- Testosterone, enclomiphene, low-dose naltrexone, rapamycin and metformin
- Hormones and longevity drugs that are not peptides.
How it bills
Each peptide is sold as a monthly subscription with 10% off, or as a one-time order. Sermorelin is $158 a month or $175 once, NAD+ injection $161 or $179, glutathione $107 or $119, NAD+ spray $134 or $149, and PT-141 $170 or $189. Longer prepaid terms cost less per month. Semaglutide is $99 for the first month and $190 a month after, and tirzepatide $149, then $239. Shipping is free above $150, so a glutathione order can carry a fee. You cancel by emailing support before renewal, though the longevity page says you can cancel in your account. A declined prescription is refunded; a dispensed one is not.
For and against
- For: Names its three dispensing pharmacies
- For: Vial strength printed on every peptide
- For: Subscribe or one-time price on every vial
- For: Unlimited follow-up messages on longevity plans
- Against: No dose printed for injected peptides
- Against: Sermorelin study is never identified
- Against: Peptide orders under $150 may pay shipping
- Against: Most of the shelf is research peptides
The evidence behind what it sells
- How Long Does It Take for Tirzepatide to Work? Appetite, Weight and the Week-12 Mark
- Vyleesi Reviews: What Women in the Trials Reported, and What the Numbers Show
- NAD+ and Glutathione: The Biochemical Link, and Whether the Pair Has Been Tested
- Sermorelin vs HGH: A Signal to the Pituitary or the Hormone Itself
- Ozempic and Alcohol: Can You Drink on Semaglutide, and Does It Curb Drinking?
- How Long Does PT 141 Last? Four Clocks, and the One Nobody Has Timed
Right for
Readers who want to know which pharmacy compounds their NAD+ or sermorelin, and who are comfortable leaving the dose entirely to the prescriber.
Look elsewhere if
Anyone who wants the dose printed before paying, or who would rather buy from a seller that does not stock research peptides beside its prescriptions.
Other sellers for weight
AgelessRx
Also prescribes Semaglutide, Tirzepatide.
AHBARx
Also prescribes Semaglutide, Tirzepatide.
Auren Rx
Also prescribes Semaglutide, Tirzepatide.
FormBlends
Frequently asked questions
- What does FormBlends sermorelin cost?
- $158 a month on subscription or $175 as a one-time order, for a 15 mg vial, with lower monthly rates on three-, six- and twelve-month terms.
- Who prescribes at FormBlends?
- Independent clinicians of a separate medical group, whom the site does not name; they may ask for a video or phone visit before prescribing.
- Does FormBlends ship to every state?
- Not everywhere yet: it lists 36 states and territories it has shipped to, and 16 more where availability is checked at assessment.
See what FormBlends prescribes today
FormBlends sets its own prices, plans and the states it serves. Check them before you start.